Regenerative Medicine Lead Generation: Where Should Leads Come From?

Regenerative medicine lead generation has four sources. You can build leads, earn them, pay for them or buy them, and each one comes with its own rule to check. But one thing decides whether any of it counts, and that’s what happens after the lead arrives. I’ll give you the map, the rule on each source, and why I’d fix the first reply before adding volume.

TLDR: A lead can come from four places: built, earned, paid or bought. Each one has a different rule to check: your own claims, paying for a referral, the platform’s ad policy, or consent. And none of it counts if nobody calls the lead back. So regenerative medicine lead generation starts with the first reply. Keep reading for the map, the rule on each source, and what to take to counsel.

Important Note

This article is for educational purposes only and does not constitute legal, medical, or regulatory advice. Marketing strategies discussed should be reviewed by qualified legal counsel before implementation, particularly regarding FDA, FTC, and state-specific advertising regulations. Regen Portal is a marketing and consulting company, not a law firm. Nothing here implies FDA approval of any product or any use. Most cell, tissue and exosome products marketed to patients are not FDA approved, and the few cell-based products the FDA has approved are approved only for specific labeled indications. Nothing here promises a marketing or business outcome. Regulations change and enforcement varies by state. Confirm current requirements with qualified legal and compliance counsel before you act on anything you read here.

Across the practices we’ve looked at, the first touch on a new inquiry ranges from a few minutes to a few days. Minutes at one practice. Days at another.

Then an owner asks me where the leads should come from. Okay, fair enough. But before I answer, I ask one back. What happens to a lead today, after it arrives?

Because that’s where I see regenerative medicine lead generation break, and the source doesn’t fix it. So here’s the map. Four sources, the rule on each one, and the first thing I’d fix.

The Short Answer on Regenerative Medicine Lead Generation: Four Sources, Four Rules

Leads come from four places. You build them with your own site and content, you earn them through referrals, you pay for them with ads, or you buy them from a lead vendor. Each one has a different rule to check, and what happens after the lead arrives decides whether any of them counts.

Owners ask about this early. When a practice owner and I talk for the first time, the opening three questions are nearly always about understanding the process, growth goals and customer flow. Customer flow is the lead question.

Why do I sort the sources this way? Because the first thing I want to know is what you own. Then the rule changes with each one, like this.

What this means for your practice: Write down which of the four you use today. Then ask who on your team has read the rule for each one.

Built: Your Site, Search and the Content You Own

Built leads come from what you own: your website, your place in search, and your email list. The rule to check is your own words, because what you publish counts as advertising.

What do you do when a friend gives you a doctor’s name? You look them up. So the other three sources lean on this one, and it’s the one I’d build first. Somebody paying out of their own pocket researches longer and compares more providers, and so your pages have to answer the questions they show up with.

So what does the rule say? The FTC’s health products guidance says advertising includes statements “on the internet and in other digital content.” Translation: your website is advertising. Your blog is advertising. And the FTC’s advertising basics page says claims in ads “must be truthful, cannot be deceptive or unfair, and must be evidence-based.”

That follows you onto the free guide too. The standard lead magnet fails a regen clinic because it promises outcomes, and a promise on a download is still a claim.

And then there’s the form. When we do a compliance review, one of the things the practice gets back is its intake forms, trimmed to what books the consult. So what does your form ask for? If it asks about a condition before anybody has talked to that person, ask yourself why you need it.

Earned: Referrals and Why Paying for Them Is a Legal Question

Earned leads come from referrals and word of mouth, like another physician or a past patient. You can’t buy this source. And the moment you pay for a referral, you have a legal question for counsel.

A referral runs on trust. And a referral from another physician never touches an ad platform, which is why I call it the cleanest patient channel.

But here’s the problem. Let’s say you want to pay the office that sends you patients, a fee for each one. Can you?

The federal Anti-Kickback Statute is explained on the OIG’s fraud and abuse page. It calls the statute “a criminal law.” It says the law prohibits knowingly and willfully paying to “induce or reward patient referrals” involving any item or service “payable by the Federal health care programs.” And then it says this: “In some industries, it is acceptable to reward those who refer business to you. However, in the Federal health care programs, paying for referrals is a crime.”

So does that reach a practice with no federal program business? I can’t give you a yes or a no on that. The federal statute is about federal health care program business. But many states have their own rules on paying for patient referrals, and state law may reach further. Counsel decides.

The same page says safe harbors exist, and that an arrangement “must fit squarely in the safe harbor and satisfy all of its requirements.” Squarely. I wouldn’t guess at that.

So earn the referral. And if money comes up, stop and call counsel.

Paid: What Google’s Ad Policy Does Not Allow

Paid leads come from ads, and the platform decides what you may advertise before you write a word. For cell therapies and PRP, Google’s ad policy doesn’t allow promotion, and the one exception is narrow. So read the policy first, then decide what to spend.

As of October 2026, Google’s ad policy on cell therapies lists this as not allowed: “Promotion of cell or gene therapies, subject to the exception below.” Platelet rich plasma (PRP) is among the examples that page gives, and so is stem cell therapy.

And the exception? Google allows ads for cell or gene therapies that are “exclusively educational or informational in nature.” So can a clinic just run an educational ad? Look at the examples Google gives. Academic papers, and tickets for medical conferences. That isn’t a clinic’s page with a booking button, and I wouldn’t build a lead plan on it.

Then there’s the audience. Google treats health as a sensitive interest category. Advertisers in sensitive categories can’t use Customer Match, their own data segments, audience expansion or lookalike segments. So remarketing and uploaded patient lists are off the table.

And if you advertise a stem cell therapy anywhere, some states now require a specific notice in the ad. The notice doesn’t change the product’s federal status, and it doesn’t change a platform’s policy. The wording differs by state, and counsel confirms which ones apply to you.

So for regenerative medicine lead generation, I’d ask one thing about any paid advertising plan, on any platform. What does the policy say about the service in the ad?

Bought: Lead Vendors, Patient Lists and Consent

Bought leads come from a vendor who sells you names, or sends you people who filled out a form somewhere else. Whether you can use them turns on consent, on where the list came from, and on how the vendor gets paid. I’d take the contract to counsel before you sign.

If a vendor tells you every lead opted in, that’s a claim. Ask to see the consent each person gave, in writing. The clinic answers for what a lead vendor or affiliate says. Approve their copy in advance and keep the record. That includes any “free” offer, cash reward or “covered” claim, because each one has to be accurate.

Why? Because you’re going to text those people, or call them. The federal rule on marketing calls and texts is 47 CFR 64.1200. It says marketing texts and automated calls need written consent first, and people need a working way to stop them. The details go to counsel.

What if somebody offers to sell you a list of patients? Ask where it came from. HHS has a page on HIPAA and marketing. It says “covered entities may not sell lists of patients or enrollees to third parties without obtaining authorization from each person on the list.”

It runs the other way too. If your practice is a HIPAA covered entity, the rule requires a person’s written authorization before their health information is used for marketing, with limited exceptions.

And pay per lead can bring back the referral question from the Earned section. The federal statute covers federal program business, state law may reach further, and counsel decides. My own rule: I treat pay per lead as off the table until counsel has cleared that exact arrangement in writing.

Treat a lead source the way you’d treat any other vendor: score it before you sign, and decide up front what would make you walk away.

What Happens to a Lead After It Arrives?

It waits, anywhere from a few minutes to a few days. That’s the range I opened with, and it depends on the practice.

Why so wide? Usually because reaching out is a task that sits with the receptionist or an admin, and it’s seldom automated. It can be, in nearly every case. And it should be.

Almost every practice I’ve sat down with shows the same pattern. In the practices I have sat down with, many inquiries arrive outside clinic hours. The bottleneck is the front desk, and follow-up is what falls off first. The leads end up in three systems, and not one of those systems talks to the other two.

Now put four sources on top of that. Can anybody on your team pull up every person who is still waiting to hear back?

Before this industry, I sold phone and internet service door to door, in the summer, in the Miami heat. Rejection, going back, following up. A lead nobody follows up on is a door nobody knocked on twice.

So before you add volume, look at the reply. A lead count can be one of those metrics that look good and mean little. More leads into a slow reply is just more people waiting, and that’s the part of regenerative medicine lead generation nobody puts on the report.

So it all goes back to the question I asked at the top. What happens to a lead today, after it arrives?

Let’s Say a Practice Fixes the First Reply Before It Buys Leads

Let’s say a practice has one physician and one nurse practitioner, and the office manager also runs the marketing. It added a regenerative service line fourteen months ago. This scenario is illustrative and does not describe any Regen Portal client.

The Challenge: The owner wants more leads and has a quote from a lead vendor on the desk. Meanwhile, the web forms that come in at night sit until the office manager has a free minute.

The Approach: The owner puts the quote down and maps the four sources first. Every inquiry goes on one list, marked by source. The first reply is automated with wording the physician approved, and a named person calls the next morning.

The Compliance Check: The automated reply says nothing about what a therapy will do, and it quotes no price. Counsel reads the vendor contract and the consent wording before anything is signed.

What Changed: Every lead gets a reply, and the owner can see where each one came from. Does that mean more patients? I wouldn’t tell anybody that. But the owner now knows what happens to a lead before paying for more of them.

Frequently Asked Questions

Can a Regenerative Medicine Clinic Buy Leads?

It depends on the consent behind each lead, on where the names came from, and on how the vendor gets paid. Marketing texts and automated calls need written consent first. And HHS says a HIPAA covered entity may not sell a list of patients without authorization from each person on it. Take the vendor contract to counsel before you sign.

Is Pay per Lead Allowed for a Cash-Pay Practice?

I treat it as off the table until counsel clears the exact arrangement in writing. The federal Anti-Kickback Statute covers items or services payable by federal health care programs, so the first question is whether any of your business touches one. Many states have their own rules on paying for patient referrals, and state law may reach further.

How Fast Should We Reply to a New Lead?

Reply at a speed your team can hold on its busiest day. I’d automate the first touch, so it doesn’t wait on a free minute at the front desk. I’m not going to give you a number. Measure your own gap first.

Which Lead Source Should Come First?

The first reply comes first, and then the source you own. After that I’d add earned, then paid inside the platform’s policy, and bought only once counsel has cleared the arrangement in writing. That’s an order by what you own and what there is to check. You can also grow without more ad spend through referrals and local search.

Should We Run Google Ads for Regenerative Medicine Lead Generation?

For a cell therapy or PRP service, I wouldn’t plan on it. Google’s ad policy doesn’t allow promotion of cell or gene therapies, and it names stem cell therapy and PRP among its examples. The exception is for ads that are exclusively educational or informational, and Google’s examples are academic papers and conference tickets.

Key Takeaways

• Regenerative medicine lead generation has four sources: built, earned, paid and bought.
• What you publish on your own site counts as advertising.
• Paying for a referral is a legal question, and counsel answers it.
• Google’s ad policy doesn’t allow promotion of cell therapies or PRP, and the exception is narrow.
• A bought lead turns on consent, on where the list came from, and on how the vendor gets paid.
• Fix the first reply before you add volume.

Questions?

Mapping this out with an owner is a lot of what I do. Where do the leads come from, and what happens to each one after it lands?

If a lead vendor’s pitch is on your desk, or a lead form you’re not sure about, email it to me.

PS: Before you sign with any lead source, find out how long a new lead waits at your practice today, and where the vendor’s names came from. Ask the questions.

Email: hello@regenportal.com

YouTube: Subscribe to the channel

About Regen Portal

Regen Portal is a marketing and consulting company built for the regenerative medicine industry. We handle practice consulting, marketing compliance, search engine optimization, content creation, social media management, paid advertising, website development, branding, and AI and ops consulting for clinics, manufacturers, distributors, and independent providers. For more on me and how we work, visit Regen Portal and contact us.

About the Author

Oscar Tellez is the founder of Regen Portal, a marketing and consulting company built for the regenerative medicine industry. He has been in this industry since 2015. He started in medical sales and has worked with PRP since 2016. He has reached hundreds of practices and over 200 doctors through sales, teaching and marketing. He holds a B.S. in Exercise Science and Health Promotion from Florida Atlantic University.